Spring 2025
By Stephanie Lowitt
The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program awarded $249,999 to Alicia Morgans, MD, MPH, to help assess and manage cardiovascular risk in patients with prostate cancer who are starting androgen deprivation therapy. Her study explores improving patient care in ways that work for clinical teams, are low burden to patients, and are scalable.